You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 3, March 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Topical Fibronectin in an Alkali Burn Model of Corneal Ulceration in Rabbits

T. Mai Phan, MD; C. Stephen Foster, MD; Carolyn D. Shaw; Luba M. Zagachin, MS; Robert B. Colvin, MD

Arch Ophthalmol. 1991;109(3):414-419.


Abstract

• We studied the effect of topical fibronectin on epithelial wound healing and ulceration in alkali-burned rabbit corneas. After the first 56 hours, fibronectin accelerated complete surface reepithelialization to 4.3±2.3 days. Control alkali-burned corneas treated with phosphate-buffered saline or albumin did not resurface for 6.7±3.7 days and 6.2±2.5 days, respectively. When recurrent epithelial defects occurred, the time required for healing was also significantly accelerated by fibronectin treatment. Corneal ulceration developed in 25 of 28 and 15 of 18 saline and albumin-treated control eyes, respectively; only nine of 18 fibronectin-treated eyes ultimately ulcerated. Immunohistologic studies showed that the initially deposited fibronectin-fibrinogen matrix on the surface of burned corneas had disintegrated by 72 to 96 hours after wounding, corresponding clinically to the time of secondary epithelial breakdown. A prominent fibronectin-fibrinogen matrix remained on the surface of fibronectin-treated corneas, presumably aiding surface reepithelialization and decreasing corneal ulceration.



Author Affiliations

From the Hilles Immunology Laboratory, Massachusetts Eye and Ear Infirmary (Drs Phan and Foster and Ms Shaw); Immunopathology Unit, Massachusetts General Hospital (Ms Zagachin and Dr Colvin); and Harvard Medical School (Drs Phan, Foster, and Clovin and Mss Shaw and Zagachin), Boston.


Footnotes

Accepted for publication October 9, 1990.

Reprint requests to Immunopathology Unit, Cox 5, Massachusetts General Hospital, Fruit Street, Boston, MA 02114 (Dr Colvin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Alkali-Induced Corneal Stromal Melting Prevention by a Novel Platelet-Activating Factor Receptor Antagonist
He et al.
Arch Ophthalmol 2006;124:70-78.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.